Multiple milestones achieved in 2026, including initiation of six pivotal trials - five for pumitamig and one for B7-H3-targeting ADC candidate elfetabart drozuntecan; upcoming 2026 catalysts include ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
BioNTech presents promising lung cancer drug data at ELCC 2026, but investor sentiment remains cautious due to revenue forecast and high pipeline stakes. The European Lung Cancer Congress 2026 in ...
BioNTech shares rally 24% on Moderna's cancer vaccine success, but investors await pivotal lung cancer data in September. The numbers look almost contradictory on paper. Revenue collapsed 76 percent ...
A coveted Presidential Symposium slot at Europe's top oncology congress just sent Moderna shares flying 9%, but the actual Phase 3 melanoma data remains unseen. Here is why the scheduling alone is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results